Bio-Rad Laboratories | BIO - Ordinary Share Capital


Bio-Rad Laboratories reported $26.99M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Abbott USD 1.74B 23.39B Sep/2025
Agilent USD 282.22M 478K Mar/2026
Becton, Dickinson and Co. USD 284.91M 1.72M Dec/2025
Bio Techne USD 156.45M 703K Mar/2026
Bio-Rad Laboratories USD 26.99M 18K Dec/2025
Bruker USD 152.22M 282K Mar/2026
Charles River Laboratories USD 48.17M 1.05M Mar/2026
Danaher USD 707.7M 800K Mar/2026
General Electric Aerospace USD 1.04B 5.43M Mar/2026
Illumina USD 151.91M 893K Mar/2026
IQVIA Holdings USD 166.9M 2.7M Mar/2026
Laboratory Of America USD 82.3M 100K Mar/2026
Merck USD 2.47B 12.72M Dec/2025
Mettler Toledo International USD 20.25M 179.94K Mar/2026
Myriad Genetics USD 93.5M 400K Dec/2025
OraSure Technologies USD 70.39M 1.87M Dec/2025
Pacific Biosciences Of California USD 301.96M 103K Dec/2025
Quest Diagnostics USD 111M 1000K Mar/2026
Repligen USD 56.4M 74K Mar/2026
Revvity USD 111.8M 1.57M Mar/2026
Roche Holding CHF 795.62M 699.54K Dec/2025
Siemens EUR 780.74M 6.33M Dec/2025
Standard Biotools USD 390.14M 3.76M Mar/2026
Thermo Fisher Scientific USD 371.62M 4.09M Mar/2026
Tosoh JPY 307.89M 2.47M Mar/2026
Waters USD 98.17M 89K Mar/2026